188 related articles for article (PubMed ID: 20808686)
1. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
2. A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
[TBL] [Abstract][Full Text] [Related]
3. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
4. A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.
Ise T; Shimoda A; Takakuwa H; Kato T; Izumiya Y; Shimizu K; Suzuki T; Sasano H; Yokoyama H; Kobayashi K
Clin Endocrinol (Oxf); 2001 Jul; 55(1):131-4. PubMed ID: 11453962
[TBL] [Abstract][Full Text] [Related]
5. A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.
Carvajal CA; Stehr CB; González PA; Riquelme EM; Montero T; Santos MJ; Kalergis AM; Fardella CE
J Endocrinol Invest; 2011 Feb; 34(2):140-4. PubMed ID: 20634641
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
7. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
[TBL] [Abstract][Full Text] [Related]
10. GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.
Wu YC; Chen CI; Chen PY; Kuo CH; Hung YH; Peng KY; Wu VC; Tsai-Wu JJ; Hsu CL;
BMC Bioinformatics; 2022 Jan; 22(Suppl 10):613. PubMed ID: 35012455
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
12. Familial hyperaldosteronism.
Torpy DJ; Stratakis CA; Chrousos GP
Braz J Med Biol Res; 2000 Oct; 33(10):1149-55. PubMed ID: 11004715
[TBL] [Abstract][Full Text] [Related]
13. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
Geller DS; Zhang J; Wisgerhof MV; Shackleton C; Kashgarian M; Lifton RP
J Clin Endocrinol Metab; 2008 Aug; 93(8):3117-23. PubMed ID: 18505761
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.
Pascoe L; Curnow KM; Slutsker L; Connell JM; Speiser PW; New MI; White PC
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8327-31. PubMed ID: 1518866
[TBL] [Abstract][Full Text] [Related]
15. Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia.
Xu L; Xia W; Wu X; Wang X; Zhao L; Nie M
Steroids; 2015 Sep; 101():51-5. PubMed ID: 26066897
[TBL] [Abstract][Full Text] [Related]
16. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
18. New genetic insights in familial hyperaldosteronism.
Jackson RV; Lafferty A; Torpy DJ; Stratakis C
Ann N Y Acad Sci; 2002 Sep; 970():77-88. PubMed ID: 12381543
[TBL] [Abstract][Full Text] [Related]
19. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction.
Yokota K; Ogura T; Kishida M; Suzuki J; Otsuka F; Mimura Y; Oishi T; Hirata M; Tobe K; Makino H
Hypertens Res; 2001 Sep; 24(5):589-94. PubMed ID: 11675955
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-remediable aldosteronism.
Halperin F; Dluhy RG
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
